News
9h
Zacks.com on MSNIs Eli Lilly Stock a Portfolio Must-Have Pre-Q2 Earnings?Eli Lilly and Company LLY will report its first-quarter earnings on May 1, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $12.62 billion and $3.52 per share, ...
6h
Zacks Investment Research on MSNIs Eli Lilly Stock a Portfolio Must-Have Pre-Q1 Earnings? (Revised)Eli Lilly and Company LLY will report its first-quarter earnings on May 1, before market open. The Zacks Consensus Estimate ...
6h
Stocktwits on MSNEli Lilly Stock Gets A Double Downgrade And Price Target Cut By HSBC Over Valuation, Competition ConcernsHSBC on Monday double downgraded Eli Lilly and Co. (LLY) stock to ‘Reduce’ from ‘Buy’ and also lowered its price target to ...
President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...
Eli Lilly has the results it was looking for in a second, confirmatory trial of its anti-IL-23p19 antibody mirikizumab in ulcerative colitis as it waits for the outcome of regulatory reviews in ...
The EMA’s human medicines advisory committee has recommended approval of Eli Lilly’s Baqsimi as the first needle-free treatment for severe low blood sugar levels (hypoglycaemia) in diabetics ...
Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...
We are on campus with a select team of staff to assist students and the University community while also continuing to provide services remotely.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results